FDA gives doctors more leeway in prescribing Genzyme's thyroid cancer drug

With a decision by the U.S. Food and Drug Administration this week, Genzyme Corp. is now free to tout the results of two large trials showing its the effectiveness at varying dose levels of its drug to treat the fastest-growing cancer in the U...